INOVIO PHARMACEUTICALS, INC. Shares Outstanding (Cover Page)
INOVIO PHARMACEUTICALS, INC. (INO) had Shares Outstanding (Cover Page) of 103.40 million shares as of 2026-08-10, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-12
- 2026-08-10: Entity Common Stock, Shares Outstanding 103.40M shares.
- 2026-05-12: Entity Common Stock, Shares Outstanding 82.27M shares.
- 2026-03-12: Entity Common Stock, Shares Outstanding 69.09M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 53.57M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 103.40M shares 10-Q · filed 2026-08-12 |
| 2026-05-12 | 82.27M shares 10-Q · filed 2026-05-13 |
| 2026-03-12 | 69.09M shares 10-K · filed 2026-03-12 |
| 2025-11-07 | 53.57M shares 10-Q · filed 2025-11-10 |
| 2025-08-08 | 53.14M shares 10-Q · filed 2025-08-12 |
| 2025-05-09 | 36.67M shares 10-Q · filed 2025-05-13 |
| 2025-03-12 | 36.67M shares 10-K · filed 2025-03-18 |
| 2024-11-12 | 26.10M shares 10-Q · filed 2024-11-14 |
| 2024-08-08 | 25.96M shares 10-Q · filed 2024-08-08 |
| 2024-05-10 | 25.91M shares 10-Q · filed 2024-05-13 |
| 2024-03-01 | 23.37M shares 10-K · filed 2024-03-06 |
| 2023-11-08 | 272.99M shares 10-Q · filed 2023-11-09 |
| 2023-08-07 | 268.07M shares 10-Q · filed 2023-08-09 |
| 2023-05-08 | 262.74M shares 10-Q · filed 2023-05-10 |
| 2023-02-24 | 260.13M shares 10-K · filed 2023-03-01 |
| 2022-11-07 | 249.49M shares 10-Q · filed 2022-11-08 |
| 2022-08-05 | 249.40M shares 10-Q · filed 2022-08-09 |
| 2022-05-09 | 229.04M shares 10-Q · filed 2022-05-10 |
| 2022-02-25 | 217.40M shares 10-K · filed 2022-03-01 |
| 2021-11-05 | 210.39M shares 10-Q · filed 2021-11-09 |
| 2021-08-06 | 210.36M shares 10-Q · filed 2021-08-09 |
| 2021-05-06 | 209.40M shares 10-Q · filed 2021-05-10 |
| 2021-02-26 | 207.63M shares 10-K · filed 2021-03-01 |
| 2020-11-05 | 169.41M shares 10-Q · filed 2020-11-09 |
| 2020-08-07 | 167.52M shares 10-Q · filed 2020-08-10 |
| 2020-05-08 | 158.10M shares 10-Q · filed 2020-05-11 |
| 2020-03-11 | 145.80M shares 10-K · filed 2020-03-12 |
| 2019-11-07 | 100.01M shares 10-Q · filed 2019-11-12 |
| 2019-08-05 | 99.03M shares 10-Q · filed 2019-08-08 |
| 2019-05-06 | 98.03M shares 10-Q · filed 2019-05-09 |
| 2019-03-08 | 97.64M shares 10-K · filed 2019-03-12 |
| 2018-11-02 | 95.35M shares 10-Q · filed 2018-11-08 |
| 2018-08-03 | 91.50M shares 10-Q · filed 2018-08-07 |
| 2018-05-04 | 90.96M shares 10-Q · filed 2018-05-09 |
| 2018-03-08 | 90.40M shares 10-K · filed 2018-03-14 |
| 2017-11-03 | 90.30M shares 10-Q · filed 2017-11-08 |
| 2017-08-04 | 90.23M shares 10-Q · filed 2017-08-08 |
| 2017-05-01 | 74.63M shares 10-Q · filed 2017-05-10 |
| 2017-03-08 | 74.10M shares 10-K · filed 2017-03-15 |
| 2016-11-01 | 74.06M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 73.55M shares 10-Q · filed 2016-08-08 |
| 2016-05-02 | 73.10M shares 10-Q · filed 2016-05-09 |
| 2016-03-07 | 72.22M shares 10-K · filed 2016-03-14 |
| 2015-11-02 | 72.18M shares 10-Q · filed 2015-11-09 |
| 2015-08-03 | 72.12M shares 10-Q · filed 2015-08-10 |
| 2015-05-05 | 71.81M shares 10-Q · filed 2015-05-11 |
| 2015-03-09 | 60.74M shares 10-K · filed 2015-03-16 |
| 2014-11-03 | 60.59M shares 10-Q · filed 2014-11-10 |
| 2014-08-04 | 60.40M shares 10-Q · filed 2014-08-11 |
| 2014-05-02 | 240.63M shares 10-Q · filed 2014-05-12 |
| 2014-03-07 | 239.61M shares 10-K · filed 2014-03-17 |
| 2013-11-04 | 208.38M shares 10-Q · filed 2013-11-12 |
| 2013-08-08 | 189.90M shares 10-Q · filed 2013-08-09 |
| 2013-05-03 | 179.94M shares 10-Q · filed 2013-05-10 |
| 2013-03-08 | 179.92M shares 10-K · filed 2013-03-18 |
| 2012-11-02 | 139.36M shares 10-Q · filed 2012-11-07 |
| 2012-08-02 | 134.97M shares 10-Q · filed 2012-08-09 |
| 2012-05-04 | 134.97M shares 10-Q · filed 2012-05-09 |
| 2012-02-21 | 134.97M shares 10-K · filed 2012-03-15 |
| 2011-10-26 | 127.27M shares 10-Q · filed 2011-11-07 |
| 2011-07-27 | 127.26M shares 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |